| pharyngeal septum |
the transitory partition which separates the mouth cavity from the pharynx in the embryo; called also buccopharyngeal membrane.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| pharyngoesophageal junction |
the area where the esophagus and pharynx meet and the pharyngoesophageal sphincter is located.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| pharmacogenetics |
The terms pharmacogenomics and pharmacogenetics tend to be used interchangeably, and a precise, consensus definition of either remains elusive. Pharmacogenetics is generally regarded as the study of genetic variation that gives rise to differing response to drugs, while pharmacogenomics is the broader application of genomic technologies to new drug discovery and further characterization of older drugs. ...
Ãâó: en.wikipedia.org/wiki/Pharmacogenetics
|
| pharmacogenomics |
Pharmacogenomics is the branch of pharmaceutics which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity. By doing so, pharmacogenomics aims to develop rational means to optimise drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. ...
Ãâó: en.wikipedia.org/wiki/Pharmacogenomics
|
| pharmacokinetics |
Pharmacokinetics is a branch of pharmacology dedicated to the study of the time course of substances and their relationship with an organism or system. In practice, this discipline is applied mainly to drug substances, though in principle it concerns itself with all manner of compounds residing within an organism or system, such as nutrients, metabolites, endogenous hormones, toxins, etc. ...
Ãâó: en.wikipedia.org/wiki/Pharmacokinetics
|